SCHEMBL17690877

SCHEMBL17690877

c1ccc(-c2ccc(-n3c4ccccc4c4ccc5c6ccc7c8ccccc8n(-c8ccc(-c9ccccc9)cc8)c7c6oc5c43)cc2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.47
KDM4E B2RXH2 2/20 0.47
ATM Q13315 1/20 0.47
HDAC4 P56524 1/20 0.39
KMT2A Q03164 4/20 0.37
IL1R1 P14778 1/20 0.37
ALDH1A1 P00352 4/20 0.36
MEN1 O00255 3/20 0.36
MAPT P10636 2/20 0.36
HTT P42858 1/20 0.36
TSHR P16473 2/20 0.35
HSD17B10 Q99714 2/20 0.35
POLB P06746 1/20 0.35
BRCA1 P38398 1/20 0.35
PTPN1 P18031 2/20 0.32
EDNRB P24530 1/20 0.32
EDNRA P25101 1/20 0.32
HSP90AA1 P07900 1/20 0.32
AVPR1A P37288 1/20 0.32
FAAH O00519 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17790379 0.98 L3MBTL1 (0.50) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL24210089 0.92 L3MBTL1 (0.40) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL24209934 0.92 L3MBTL1 (0.40) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL24209969 0.92 L3MBTL1 (0.40) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL17690864 0.92 L3MBTL1 (0.44) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL17246035 0.91 KDM4E (0.42) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL24210056 0.91 L3MBTL1 (0.42) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL17690930 0.91 L3MBTL1 (0.42) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL24209947 0.91 L3MBTL1 (0.42) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL17690903 0.91 L3MBTL1 (0.42) L3MBTL1KDM4EATMHDAC4KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160155955-A1 DICARBAZOLE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICES HODOGAYA CHEMICAL CO., LTD. (JP) 2016-06-02 US disclosed
US-20160155955-A1 DICARBAZOLE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICES HODOGAYA CHEMICAL CO., LTD. (JP) 2016-06-02 US disclosed
EP-3009438-A1 DICARBAZOLE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT Hodogaya Chemical Co., Ltd. (JP) 2016-04-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160155955-A1 DICARBAZOLE DERIVATIVES AND ORGANIC ELECTROLUMINESCENT DEVICES AHR, NAT1, NR2C2 L3MBTL1 3275/4885KDM4E 3189/4885ATM 1246/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.